Pharm-Olam LLC, announces the appointment of Fabiola Encinas as the Country Operations Manager for Mexico.
JUNE 27, 2016
HOUSTON, TEXAS – Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO), serving the biopharmaceutical and medical device industries, announces the appointment of Fabiola Encinas as the Country Operations Manager for Mexico. Ms. Encinas has over 11 years of experience in the management of development programs throughout Latin America specializing in local team leadership, ensuring efficient and effective trial management.
Pharm-Olam’s Country Operations Managers (COM) play a vital role in study management, acting as experts for their respective countries, optimizing local operations, advising on Regulatory requirements and procedures, and overseeing local site management, feasibility and recruitment.
“Fabiola is an important addition to the Pharm-Olam team,” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer. Suri added, “Our COMs play a pivotal role in our global studies, providing local expertise and allowing us to share local knowledge and best practices with our clients. We are excited to have Fabiola on board.”
For more information about Pharm-Olam and its global Phase I-IV clinical research solutions, contact info@pharm-olam.com (link sends e-mail).
About Pharm-Olam International Group
Pharm-Olam International is a multi-national Contract Research Organization (CRO) offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. For further information about Pharm-Olam, please visit www.pharm-olam.com.